Recommendation Updates

Follow the latest news on active Turnaround Letter purchase recommendations.

Small Cap / Post-Bankruptcy Stocks / Materials / Pharmaceuticals, Biotechnology & Life Sciences

Solutia Affirmation, Dividend Announced

On December 15, 2011, Solutia Inc. (NYSE: SOA) announced that it has affirmed its 2011 Adjusted Earnings per Share guidance for 2011 of approximately $2.00 and outline 2012 expectations for revenue of $2.125 billion to $2.275 billion and Adjusted EPS of $2.00 to $2.30. The Company’s Board of Directors also declared a quarterly cash dividend of $0.0375 per share on the Company's common stock, equivalent to an annual dividend of 15 cents per share or approximately a 1% dividend yield. The dividend is payable on March 15, 2012 to shareholders of record at the close of business on February 15, 2012.

Read More Purchase Recommendation Updates

Identify & Profit from Distressed Investing

Free Report: Turnaround Investing Mistakes

Turnaround Investing Blog

Turnaround Investing Blog

Is there value in bankrupt PG&E’s stock?

In nearly every case, the shares of a company in bankruptcy become worthless. In very rare cases, however, they can become great investments. W.R. Grace (NYSE:GRA) shares produced a 75-fold return, as an example. With California utility PG&E (NYSE:PCG) now in bankruptcy, the range of possible outcomes for its equity is wide.

Read More.

EV/EBITDA: What Is It & Why Are We Using It More?

In reading recent editions of The Turnaround Letter, you have probably noticed that we are increasingly using EV/EBITDA as a valuation measure, rather than the better-known price/earnings multiple.  We thought it might be useful to describe this measure and why we like it.

Read More.

Turnaround Letter Stock Pick Named Top Performer of 2017

 

stock market advicex

 

What Last Year's Top Stock Pickers Are Buying in 2018

 

This Forbes write-up follows up on the recent Top Stock Tips report--naming The Turnaround Letter's Crocs recommendation the top performer of 2017: With 90% gains, CROX beat out 100 other investment ideas included in the report; and the stock continues to have value investing appeal, according to Putnam.

 

George notes, "We see additional upside for the stock in 2018 as management's efforts continue to bear fruit, though the gains will likely be more muted than we saw in 2017."